title: Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir.
authors.forename: M
authors.initials: M
authors.lastname: Luppi
authors.forename: R
authors.initials: R
authors.lastname: Trovato
authors.forename: P
authors.initials: P
authors.lastname: Barozzi
authors.forename: D
authors.initials: D
authors.lastname: Vallisa
authors.forename: G
authors.initials: G
authors.lastname: Rossi
authors.forename: A
authors.initials: A
authors.lastname: Re
authors.forename: L
authors.initials: L
authors.lastname: Ravazzini
authors.forename: L
authors.initials: L
authors.lastname: Potenza
authors.forename: G
authors.initials: G
authors.lastname: Riva
authors.forename: M
authors.initials: M
authors.lastname: Morselli
authors.forename: G
authors.initials: G
authors.lastname: Longo
authors.forename: L
authors.initials: L
authors.lastname: Cavanna
authors.forename: R
authors.initials: R
authors.lastname: Roncaglia
authors.forename: G
authors.initials: G
authors.lastname: Torelli
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D000077404:Cidofovir; D003596:Cytosine / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019288:Herpesvirus 8, Human / Q000187:drug effects*; D006801:Humans; D015552:Injections, Intralesional; D016393:Lymphoma, B-Cell / Q000188:drug therapy* / Q000821:virology; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000821:virology; D008297:Male; D063065:Organophosphonates / Q000008:administration & dosage* / Q000627:therapeutic use; D012074:Remission Induction; D013997:Time Factors
chemical_list: D000970:Antineoplastic Agents; D063065:Organophosphonates; D003596:Cytosine; D000077404:Cidofovir